Abstract

 
 
 
 Purpose: To investigate the effect of propofol on lung metastasis of circulating tumor cells (CTCs) after colorectal cancer (CRC) surgery, and the mechanism involved.
 Methods: Specific-pathogen-free (SPF) male BALB/c mice (n = 30; mean age = 7 ± 1 weeks; mean weight = 19 ± 3 g) were used for this study. To establish mouse model of CRC, 100 μL of CRC (CT26) cells was injected into the caudal vein of each mouse. Three groups of 10 mice were used: control, 5 μL/mL propofol, and 10 μL/mL propofol groups. Changes in pulmonary superficial nodules of mice lungs were determined. Colorectal cancer cell (CT26) proliferation and apoptosis were measured using Ki-67 immunohistochemical staining and in situ terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL) assays, respectively.
 Results: The number of pulmonary nodules and proportion of proliferating cells (Ki-67 expression level) were significantly higher in 5 μL/mL propofol-treated mice, relative to control, but markedly lower in 10 μL/mL propofol group than in 5 μL/mL propofol group (p < 0.05). Although apoptotic index increased in 5 μL/mL propofol group, cell apoptosis was comparable among the groups (p > 0.05).
 Conclusion: These results suggest that propofol promotes pulmonary metastasis of CTCs after CRC surgery via stimulation of CTC proliferation in the lungs. Therefore, caution should be exercised in the use of propofol in colorectal cancer surgery.
 
 
 
Highlights
This study investigated the effect of propofol on lung metastasis of circulating tumor cells (CTCs) after Colorectal cancer (CRC)
The number of pulmonary nodules was significantly higher in 5 μL/mL propofol-treated mice, relative to control, but was markedly lower in 10 μL/mL propofol group than in 5 μL/mL propofol group (p < 0.05; Table 1)
This study investigated the effect of propofol on lung metastasis of CTCs after CRC surgery and the mechanism involved
Summary
The number of tumor patients has increased significantly over time, with malignant tumor becoming one of the most important causes of death globally. Colorectal cancer (CRC) is a type of cancer prevalent among the Chinese. It is characterized by high incidence and mortality which have continued to rise on annual basis [1]. Colorectal cancer (CRC) patients often miss diagnosis and treatment because early symptoms of the disease are usually not obvious. Prognosis is usually poor, since CRC patients are either in the middle or advanced stage of the disease at the time of diagnosis [2]. Metastasis seriously affects effectiveness of cancer treatment. Surgical resection is the main treatment strategy for CRC. Studies have shown that even after complete
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
